You can narrow down the results using the filters
-
HPV VLP as adjunct therapy for genital warts
Expand descriptionAnticipated trial start date: February 2006 (Brisbane), November 2005 (Wenzhou China) Target sample size: 240 (120 male, 120 female) at each site
-
A randomised controlled trial to reduce further falls and injuries for older fallers presenting to an Emergency Department.
Expand description -
Performance Evaluation of the GIVEN Patency System
Expand description -
Evaluation of the PillCam ESO Capsule in the Detection of Esophageal Varices
Expand description -
Evaluation of Cognitive Behavioural Therapy programme for insomnia
Expand description -
Efficacy of 8 weeks open label aripiprazole as augmentation therapy in Bipolar II disorder
Expand descriptionStudy approved
-
A multi-centre, randomised, controlled trial of bronchoalveolar lavage (BAL) directed therapy in young children with cystic fibrosis (CF).
Expand description1. This study will examine the use and safety of FB and BAL to identify lower respiratory tract infection (especially PA) in infants and young children with CF and direct therapy in an attempt to eradicate proven early lung infection. 2. The role of infection and inflammation in the development of CF lung disease will be examined in a large cohort of CF infants recruited prospectively and followed longitudinally.
-
Mechanisms of Action of an ATTORI Celery Seed Extract in Osteoarthritis
Expand description -
Pravastatin for Hyperlipidaemia in HIV.
Expand descriptionThis study is a randomised, placebo-controlled study of the effect of treatment with the HMG-CoA reductase inhibitor, pravastatin, in HIV-infected, protease inhibitor treated patients with high serum cholesterol. We hypothesise that pravastatin will result in greater reductions in cholesterol than placebo when used in conjunction with appropriate dietary advice.
-
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA 001)
Expand descriptionA prospective, non-randomised, 48 week study of the effect of PI containing and non-PI containing antiretroviral regimens on the expression of adipocyte specific genes, protein levels and cellular structure in HIV-infected individuals, naive to therapy, who are starting therapy for the first time.